Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial. Ma TM, Lamb JM, Casado M, Wang X, et al. BMC Cancer 2021;21:538.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma TM, Lamb JM, Casado M, Wang X, et al. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial. BMC Cancer 2021;21:538.
PMID: 33975579